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Method: The CIED was a one-time survey initiated by the Indian
Society of Electrocardiology (ISE) and the Indian Heart Rhythm
Society (IHRS). The device survey forms were distributed to im-
planters across many centres in India. A total of 2117 device sur-
vey forms from 136 centres were collected from April 2012 to
March 2013.
Results: Pacemaker constituted almost 80% of the devices
implanted in India. The CIED were more frequently implanted in
males (64%) and in the sixth and seventh decade of life (51%).
Complete atrio-ventricular (AV) block was the indication of
pacemaker implantation in almost 80% of the patients. 54% pa-
tients received a single chamber pacemaker. In the ICD group
(10%), single chamber ICD was used in 65%; as a primary pro-
phylaxis indication in 52.5% and most often implanted in patients
with coronary artery disease (CAD). In theCRT group (10%), CRT-P
was used in 57% of these patients, 82% were in NYHA class III or
more and the left ventricular ejection fraction (LVEF) < 0.35 in 88%
of the patients.
Conclusion: Bradycardia pacemakers are the most common CIED
implanted in India with complete AV block being the indication in
vastmajority. In the ICD group, single chamber device was used in
two-thirds of the patients and primary prophylaxis use of ICD was
common. CRT-P devices were mainly used in patients with NYHA
III or more and LVEF < 0.35 or less.
Prognosis of drug-induced atrioventricular block
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Background: PM implantation is usually not considered in drug
related bradyarrhythmia (DRB). However, it is not clear whether
AV block is really caused by drugs or it merely exposes an un-
derlying AV conduction disease.
Methods: We prospectively studied 72 consecutive patients (66±
12 yrs, 42% women) with DRB (b-blockers, calcium channel
blockers and digitalis ) between February 2009 & march 2014.Pa-
tients with symptomatic type II 2 or 3 AV block ,2:1 AV block,
sinus bradycardia  40/min, AF with average V rate  40/min or
pause >5 secs were included in the study. Patients were excluded
if their AV block was attributed to acute MI, electrolyte imbal-
ances, digitalis toxicity and other antiarrhythmic drugs. Patients
were classified into 3 groups:1. DRB resolved after the discontin-
uation of culprit drug 2.DRB persisted after drug withdrawal or
recurred after initial resolution 3.DRB with undetermined corre-
lation: PM implanted and medication continued. The mean
follow-up duration was 16 ± 9 months.
Results: The level of AVB was infranodal in 51%, AV-nodal in 37 %
& undetermined in 12%. Drug discontinuation was followed by
resolution of AV block in 57% patients. However, 37 % patients
with resolution of AVB had recurrence in the absence of culprit
drug. Six patients had early recurrence during index hospitaliza-
tion. In 31% AVB persisted even after the discontinuation of
drugs.PM was implanted in all patients with persistent or recur-
rent AVB despite withdrawal of drug. Two patients with DRB-
undetermined relation underwent pacemaker implantation and
the medication continued. Thirty five patients with resolution of
AV block were discharged & followed up for an average of 16± 9
months. Two patients died and 9 patients had recurrence of AV
block in the absence of the culprit drugs.
Conclusions: Half of our patients (54%) with DRB had persistent
indication for PMevenafterwithdrawal ofAVblockers. PossiblyAV
blocking drugs merely exposed underlying AV conduction defect.
Ivabradine in AV nodal disease on dual chamber
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Background: The use of ivabradine as a rate reducing drug is well
documented. In normotensive individuals and those with
obstructive airway disease, the use of other rate reducing drugs
like beta blockers and calcium channel blockers have limitations.
Patients with AV nodal disease can have high atrial rates when
they have a dual chamber pacemaker implanted. The high atrial
rates are translated into high ventricular rates as the atrium is
tracked and ventricle is paced, often at the upper tracking rate
which is undesirable for the patient. The study focuses on the
novel use of ivabradine in reducing the atrial rate in patients with
AV nodal disease on dual chamber pacing.
Methods: During a 2 year period from July 2011 to July 2013, 85
patients with A-V block had dual chamber pacemaker implanted.
Within 3 months of implantation 12 patients presented with
palpitation. All the patients were on dual chamber rate respon-
sive pacemaker (DDDR). All of them had AV nodal disease
ecomplete AV dissociation in 8 and high degree AV block in 4
patients. On interrogation, all of them had high atrial rate epi-
sodes ranging from 90 to 116 beats per minute. Patients were put
on ivabradine 5mg twice daily in 8 patients and 7.5mg twice daily
in 4 patients.
Results: Out of the 12 patients, 9 were females and 3 weremales. 7
patients were diabetics. Obstructive airway disease in 5 and 3 of
them were hypertensive. The average incidence of ventricular
pacing was 96%. Atrial sensed ventricular pacing (AS-vp) was
noted on interrogation in11/12 patients (91.6%) Atrial paced ven-
tricular sensing (as-vp) in 1 patient .The patients could not
tolerate betablockers or calcium channel blockers. The average
ventricular pacing rate before ivabradine was 96/min(82-104- 96%
CI).The average dose of Ivabradine was 5mg twice a day in 8
patients(66%).In 4 patients the dosage requirement was 7.5mg
twice a day(33%).After administration of ivabradine ,the the
average pacing rate reduced significantly in all the patients. The
average rate of ventricular pacing was 80/min (76- 84- 98%CI) (p
<0.05) which was significantly less than the pre ivabradine rate.
Conclusion: The administration of ivabradine in patients on dual
chamber pacemaker with high atrial rates significantly reduces
the atrial rate and reduces the rate of atrial tracked ventricular
pacing.
Busting the myth of ventricular dysfunction
secondary to dyssynchrony in WPW syndromes
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Background: Ventricular dyssynchrony has been held responsible
for impaired LV function in pre-excitation syndromes especially
with left sided and posteroseptal accessory pathways (APs) due to
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eccentric ventricular mechanical activation. In clinical practice,
overt LV dysfunction is not noted in patients with WPW syn-
drome. The aim of the study was to evaluate the functional con-
sequences of pre-excitation induced mechanical dyssysnchrony
in WPW syndrome.
Methods: Transthoracic echocardiography with TD and Strain
imaging prior to and after (median: 1 day) successful RFA were
analysed in 16 patients with pre-excitation whose electrocardio-
grams were suggestive of a right free wall (RFW-AP; n¼8) or septal
accessory pathway (S-AP; n¼8).
Results: There was no significant depression of LV function in
both groups prior to the procedure with a fractional shortening
(FS) of 35.56 ± 4.24 % and a LVEF of 64.00 ± 1.93 % in the RFWAP
group and a FS of 38.53 ± 2.04 % and LVEF of 62.75 ± 1.67 % in the S-
AP group (p value ¼ 0.141 and 0.147). The difference in the aortic
and pulmonary pre-ejection periods e Inter Venticular Mechani-
cal Delay (IVMD), taken as a measure of interventricular dyssyn-
chrony was 28.63 ± 1.41 ms and 29.25 ± 3.62 ms in right free wall
and septal group. Septal-to-posterior wall motion delay (SPWMD)
as a global measure for LV dyssynchrony showed a decrease in
both groups after successful RFA (61.25 ± 46.43 ms to 26.25 ± 36.62
ms in the right free wall group and 125.00 ± 34.64 ms to 28.75 ±
24.17 ms in the S-AP group. Further analysis with spectral TD, TVI
and longitudinal/radial strain evaluated as the time difference of
QRS onset to peak strain between opposing walls showed no sig-
nificant intraventricular dyssynchrony.
Conclusions: WPW syndromes with RFW or septal APs donot
cause significant inter or intraventricular dyssynchrony and
donot jeopardize global LV function even though SPWMD showed
improvement after RFA in the septal AP group.
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Background: Studies aimed at understanding the demographic,
clinical and interventional therapy indication profiles of Indian
cardiac arrhythmia (CA) and heart failure (HF) patients are scarce.
The purpose of the India PANARrhythMia and Heart Failure Reg-
istry (PANARM HF) was to enroll symptomatic cardiac arrhythmia
and heart failure patients presenting to physicians. Their de-
mographic and cardiovascular profiles were noted. The need for
interventional device/radiofrequency ablation (RFA) therapy as
well as their referral and consultation patterns to interventional
specialists were also recorded.. The results of the registry may
provide information to improve the diagnosis, management and
interventional therapy access of these patients.
Methods: The study included patients seen by non-interven-
tional Consulting Physicians (CP) who medically manage CA and
HF patients and refer them to interventional cardiologists (IC) for
advanced treatment like RF ablation or device implantations. CPs
were trained by ICs to apply a diagnosis protocol (DP) that
recorded details of history, physical exam, ECG and echo to
identify CA/HF patients. 59 CPs evaluated 2205 patients from
over 12 cities across India over a 2 year period. Sixteen ICs ratified
the diagnosis and prescribed appropriate therapy. Registry data
was analyzed to construct detailed demographic, clinical and
device/RFA therapy indication profiles for CA/HF patients pre-
senting to the CP.
Results: The CA/HF distribution of the 2205 patients enrolled were
as follows: HF-58%, bradyarrhythmia-15%, atrial fibrillatione15%,
other supraventricular tachyarrhythmia-10% and ventricular
tachycardia/fibrillatione4.5%. Thirty percent patients presented
with syncope/pre-syncope. The CA/HF population was predomi-
nantly male (62%) and almost 50% were below age 60. Coronary
artery disease (52%), hypertension (44%), diabetes (30%) &
myocardial infarction (20%) were the most prominent clinical
profile of these patients. 64% of the HF patients already had
advanced HF (NYHA III & IV) when they presented to the CP. Sinus
Node Dysfunction (SND) was the most common cause of bra-
dyarrhythmia (55%) compared to 2nd and 3rd degree heart block
(45%).
1011 (46%) of the CA/HF population were potential device/RFA
therapy candidates according to the ICs. 69% of these patients
were referral to the IC. Of the referred patients, only 25% con-
sulted the IC and were recommended therapy. Thus, 83% of pa-
tients in need of interventional therapy did not receive it.
Conclusion: The PANARM HF represents the first detailed de-
mographic and clinical, profiling of CA/HF patients in India. It
provides insight into the referral pattern and penetration of
interventional therapy.
Single center experience of fluoroless AVNRT
ablation guided by 3D Electro-anatomic mapping
Surendra K. Chutani, Manjinder Singh Sandhu
Artemis Hospital, Gurgaon, India
Background: Catheter ablations are traditionally performed using
fluoroscopic guidance, exposing both patients andmedical staff to
the risks of radiation. The purpose of this study was to evaluate
the feasibility, safety, and efficacy of fluoroless catheter ablation
using 3D Electroanatomical mapping (EAM) in adults being treated
for AVNRT.
Methods: 18 consecutive patients (age 17-67 years) symptomatic
for AVNRT diagnosed on ECG as short RP narrow QRS tachycardia
with typical negative p waves in II,III,aVf and pseudo r in V1,were
prospectively enrolled to right atrium 3D EA mapping and elec-
trophysiological study and radio frequency ablation (RFA) guided
by slow-pathway potential and performed using a 4-mm-tip
catheter.
Results: Sustained slow-fast AVNRT was inducible in all the pa-
tients with a dual AV nodal physiology. Entrainment from RV was
possible in all patients. Post pacing interval and typical VAV
phenomenon confirmed diagnosis of AVNRT and AVRT and AT
were ruled out. Acute success was achieved in 100% of the pa-
tients with a median of four RFA.. Fluoroless ablation was feasible
in all patients using electroanatomical map on En Site system.,
while in two subjects 50 seconds and 45 seconds of x-ray were
needed due to difficult progression of the catheters along the
i n d i a n h e a r t j o u rn a l 6 6 ( 2 0 1 4 ) s 1es 1 4 3S128
